Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.
Start | Author Index

901.O4.8 Patterns of Care

Tuesday, December 9, 2008: 7:00 AM-9:00 AM
120-121-122-123-124-125 - North (Moscone Center)
Moderators:
Erica Campagnaro, MD and Christopher R. Flowers, MD
7:00 AM
878
Impact of Combined Anti-Retroviral Therapy on HIV-Associated Non-Hodgkin-Lymphoma - a Prospective European Multi-Cohort Study on Behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group

Julia Bohlius, MD, MScPH

University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland
7:15 AM
873
Rates of Preventable Hospitalization for Ambulatory Care Sensitive Conditions (ACSCs) among Patients with Lymphoid Malignancies (LM)

Jeffrey Alan Jones, MD, MPH, Joseph M Flynn, DO, MPH and John C. Byrd, MD

Division of Hematology, Ohio State University Medical Center, Columbus, OH
7:30 AM
874
Survival Disparities in Patients with Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study

Fausto R Loberiza Jr., MD, MS1, Anthony J Cannon2*, Dennis D Weisenburger, MD3, Julie M. Vose, MD3, Matt J. Moehr, MS2*, Martin A. Bast2*, Philip Bierman, MD2, R. Gregory Bociek, MD2 and James Olen Armitage, MD2

1University of NE Med. Ctr., Omaha, NE
2University of Nebraska Medical Center, Omaha, NE
3Univ. of NE Med. Ctr., Omaha, NE
7:45 AM
875
Does Living Closer to a Medical Care Center Matter in Sickle Cell Disease?

Jude C Jonassaint, RN1*, Charles R. Jonassaint, MA1*, Charlene M. Flahiff, MS1*, Andrea Ball, MA1*, Soheir S. Adam, M.D.2, Marilyn J Telen, MD1* and Laura M. De Castro, MD1

1Comprehensive Sickle Cell Center, Duke University, Durham, NC
2Medicine/ Hematology, UNC, Chapel Hill, NC
8:00 AM
876
Patterns of Treatment among Patients with Recently-Diagnosed Myelodysplastic Syndromes in a National Registry, 2006-2008

Carla M. Van Bennekom, MPH1*, Gregory Abel, MD, MPH2, Theresa Anderson, RN1*, Richard M. Stone, MD3 and David W. Kaufman, ScD1

1Slone Epidemiology Center, Boston University, Boston, MA
2Dana-Farber Cancer Inst., Boston, MA
3Dana-Farber Cancer Institute, Boston, MA
8:15 AM
877
Trends in Survival after Diagnosis with Hematologic Malignancy in Adolescence or Young Adulthood in the United States, 1981-2005

Dianne Pulte, MD1, Adam Gondos2* and Hermann Brenner2*

1VA New York Harbor Health Care System, New York, NY
2German Cancer Research Center, Heidelberg, Germany
8:30 AM
872
Validating the Follicular Lymphoma International Prognostic Index (FLIPI) Using SEER-Medicare Claims Data

Mark Danese, MHS, PhD1*, Robert Griffiths, ScD1*, Michelle Gleeson, PhD1* and Kevin Knopf, MD2

1Outcomes Insights, Inc, Newbury Park, CA
2Pacific Hematology/Oncoloyg Assoc., San Francisco, CA
8:45 AM
879
Randomized Controlled Trial of Supervised Patient Self-Testing of Warfarin Therapy Using An Internet Based Expert System

Fiona Ryan, MPharm1*, Stephen Byrne, MPharm, PhD1* and Susan O'Shea, M.D, M.H.S2

1School of Pharmacy, University College Cork, Cork, Ireland
2Department of Hematology, Cork University Hospital, Cork, Ireland
See more of: Oral and Poster Abstracts
<< Previous Session | Next Session >>

*signifies non-member of ASH